Interparfums Q3 revenue edges past expectations on Europe strength

By Reuters News


Overview

  • Global fragrance producer's Q3 revenue was flat yr/yr, slightly beating analyst expectations

  • European operations Q3 sales rose 4%, offsetting a 7% decline in U.S. sales

  • U.S. sales fell due to $10 mln in delayed shipments, revenue to be recognized in Q4


Outlook

  • Company maintains a measured but positive outlook for the rest of 2026 and 2027

  • Company expects 2026 holiday season and 2027 to benefit from new launches and brand additions

  • Company sees major developments planned for 2027 and beyond


Result Drivers

  • EUROPEAN GROWTH - Co said strong European sales offset weaker U.S. performance

  • SUPPLY CHAIN DELAYS - Co attributed U.S. sales decline to $10 mln in delayed giftset shipments

  • MIDDLE EAST CONFLICT - Co said ongoing war in Middle East was a 1% headwind in Q3


Company press release:


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Revenue

Slight Beat*

$430 mln

$426.89 mln (3 Analysts)

*Applies to a deviation of less than 1%; not applicable for per-share numbers.


Analyst Coverage

  • The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 3 "strong buy" or "buy", 3 "hold" and 1 "sell" or "strong sell"

  • The average consensus recommendation for the personal products peer group is "buy."

  • Wall Street's median 12-month price target for Interparfums Inc is $128.00, about 11.5% above its October 19 closing price of $114.75

  • The stock recently traded at 22 times the next 12-month earnings vs. a P/E of 21 three months ago


Reuters Recommended Reads

  • Oct 20 - France's EssilorLuxottica Q3 revenue rises on wearables, myopia management portfolio growth

  • Oct 19 - France's Virbac Q3 revenue rises on strength in Both Companion Animal, Farm Animal segments


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.
The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.
To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.
 

Cryptocurrency-related content is intended solely as news and market commentary. Crypto Derivatives are not available to Retail clients registered with Capital Com (UK) Ltd.